Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9011)
All Articles published online
|
Publishing Process of This Article
|
May 14, 2020 (publication date) through Nov 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Qiu LW, Liu YF, Cao XQ, Wang Y, Cui XH, Ye X, Huang SW, Xie HJ, Zhang HJ. Annexin A2 promotion of hepatocellular carcinoma tumorigenesis via the immune microenvironment. World J Gastroenterol 2020; 26(18): 2126-2137 [PMID: 32476780 DOI: 10.3748/wjg.v26.i18.2126] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v26/i18/2126.htm |
| Number | Citing Articles |
| 1 |
Katherine E. Lindblad, Marina Ruiz de Galarreta, Amaia Lujambio. Tumor-Intrinsic Mechanisms Regulating Immune Exclusion in Liver Cancers. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.642958
|
| 2 |
Sonia Guadalupe Barreno-Rocha, Sandra Guzmán-Silahua, Sinaí-del-Carmen Rodríguez-Dávila, Guadalupe Estela Gavilanez-Chávez, Ernesto Germán Cardona-Muñoz, Carlos Riebeling-Navarro, Benjamín Rubio-Jurado, Arnulfo Hernán Nava-Zavala. Antiphospholipid Antibodies and Lipids in Hematological Malignancies. International Journal of Molecular Sciences 2022; 23(8): 4151 doi: 10.3390/ijms23084151
|
| 3 |
Esraa Magdy Abdelraouf, Raghda R.S. Hussein, Ahmed Hassan Shaaban, Hany A.M. El-Sherief, Azza S. Embaby, Seham A. Abd El-Aleem. Annexin A2 (AnxA2) association with the clinicopathological data in different breast cancer subtypes: A possible role for AnxA2 in tumor heterogeneity and cancer progression. Life Sciences 2022; 308: 120967 doi: 10.1016/j.lfs.2022.120967
|
| 4 |
Xuezhi Li, Xiaodong Qu, Songbo Li, Kexin Lin, Nuo Yao, Na Wang, Yongquan Shi. Development of a Novel CD8+ T Cell-Associated Signature for Prognostic Assessment in Hepatocellular Carcinoma. Cancer Control 2024; 31 doi: 10.1177/10732748241270583
|
| 5 |
Yanjie Huang, Mengzhen Jia, Xiaoqing Yang, Hongyan Han, Gailing Hou, Liangliang Bi, Yueli Yang, Ruoqi Zhang, Xueru Zhao, Chaoqun Peng, Xinshou Ouyang. Annexin A2: The diversity of pathological effects in tumorigenesis and immune response. International Journal of Cancer 2022; 151(4): 497 doi: 10.1002/ijc.34048
|
| 6 |
Haijian Zhang, Yifei Liu, Xiaoqing Cao, Wenmiao Wang, Xiaohong Cui, Xuechao Yang, Yan Wang, Jiahai Shi. Nrf2 Promotes Inflammation in Early Myocardial Ischemia-Reperfusion via Recruitment and Activation of Macrophages. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.763760
|
| 7 |
Chenyue Li, Zichang Zhao, Shihong Zhao. Annexin A2 promotes development of retinal neovascularization through PI3K/ AKT signaling pathway. Current Eye Research 2022; 47(4): 579 doi: 10.1080/02713683.2021.2018467
|
| 8 |
Miner Hu, Xiaojun Xia, Lichao Chen, Yunpeng Jin, Zhenhua Hu, Shudong Xia, Xudong Yao. Emerging biomolecules for practical theranostics of liver hepatocellular carcinoma. Annals of Hepatology 2023; 28(6): 101137 doi: 10.1016/j.aohep.2023.101137
|
| 9 |
Huhu Zhang, Xiaolei Dong, Xiaoyan Ding, Guoxiang Liu, Fanghao Yang, Qinghang Song, Hongxiao Sun, Guang Chen, Shuang Li, Ya Li, Mengjun Wang, Tingting Guo, Zhe Zhang, Bing Li, Lina Yang. Bufalin targeting CAMKK2 inhibits the occurrence and development of intrahepatic cholangiocarcinoma through Wnt/β-catenin signal pathway. Journal of Translational Medicine 2023; 21(1) doi: 10.1186/s12967-023-04613-6
|
| 10 |
Wei Han, Fan Yu, Wei Guan. Oncogenic roles of lncRNA BLACAT1 and its related mechanisms in human cancers. Biomedicine & Pharmacotherapy 2020; 130: 110632 doi: 10.1016/j.biopha.2020.110632
|
| 11 |
Shu-Wei Huang, Yen-Chin Chen, Yang-Hsiang Lin, Chau-Ting Yeh. Clinical Limitations of Tissue Annexin A2 Level as a Predictor of Postoperative Overall Survival in Patients with Hepatocellular Carcinoma. Journal of Clinical Medicine 2021; 10(18): 4158 doi: 10.3390/jcm10184158
|
| 12 |
Junjian Li, Zhengpin Yu, Qiandong Zhu, Chonglin Tao, Qigang Xu. hsa_circ_102559 Acts as the Sponge of miR-130a-5p to Promote Hepatocellular Carcinoma Progression Through Regulation of ANXA2. Cell Transplantation 2020; 29: 096368972096874 doi: 10.1177/0963689720968748
|
| 13 |
Davide Brocco, Paola Lanuti, Damiana Pieragostino, Maria Concetta Cufaro, Pasquale Simeone, Giuseppina Bologna, Pietro Di Marino, Michele De Tursi, Antonino Grassadonia, Luciana Irtelli, Laura De Lellis, Serena Veschi, Rosalba Florio, Luca Federici, Marco Marchisio, Sebastiano Miscia, Alessandro Cama, Nicola Tinari, Piero Del Boccio. Phenotypic and Proteomic Analysis Identifies Hallmarks of Blood Circulating Extracellular Vesicles in NSCLC Responders to Immune Checkpoint Inhibitors. Cancers 2021; 13(4): 585 doi: 10.3390/cancers13040585
|
| 14 |
Kaiming Ma, Xin Chen, Weihai Liu, Yang Yang, Suhua Chen, Jianjun Sun, Changcheng Ma, Tao Wang, Jun Yang. ANXA2 is correlated with the molecular features and clinical prognosis of glioma, and acts as a potential marker of immunosuppression. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-00366-8
|
| 15 |
Nehal Abd El-Ghaffar Heabah, Sara A. Darwish, Fatma MKh Ibrahim. Prognostic significance of annexin A2 and tumor associated macrophages (TAMs) in metastatic renal cell carcinoma and their relation to Sunitinib resistance. Journal of Immunoassay and Immunochemistry 2024; 45(1): 1 doi: 10.1080/15321819.2023.2285501
|
| 16 |
Huhu Zhang, Fulin Sun, Shuyao Jiang, Fanghao Yang, Xiaolei Dong, Guoxiang Liu, Mengjun Wang, Ya Li, Mohan Su, Ziyuan Wen, Chunjuan Yu, Chenkai Fan, Xiaoxia Li, Zhe Zhang, Lina Yang, Bing Li. METTL protein family: focusing on the occurrence, progression and treatment of cancer. Biomarker Research 2024; 12(1) doi: 10.1186/s40364-024-00652-3
|
| 17 |
Murilo Ramos ROCHA, Jose Andres Morgado‐Diaz. Epithelial‐Mesenchymal Transition in colorectal cancer: Annexin A2 is caught in the crosshairs. Journal of Cellular and Molecular Medicine 2021; 25(22): 10774 doi: 10.1111/jcmm.16962
|
| 18 |
Liping Ren, Xianrun Pan, Lin Ning, Di Gong, Jian Huang, Kejun Deng, Lei Xie, Yang Zhang. Construction of a Combined Hypoxia-related Genes Model for Hepatocellular
Carcinoma Prognosis. Current Computer-Aided Drug Design 2023; 19(2): 150 doi: 10.2174/1573409919666221223123610
|
| 19 |
WenBo Wu, GaoZhen Jia, Lei Chen, HaiTao Liu, ShuJie Xia. Analysis of the Expression and Prognostic Value of Annexin Family Proteins in Bladder Cancer. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.731625
|
| 20 |
Xingxing Lu, Yan Mei, Chunmei Fan, Pan Chen, Xiayu Li, Zhaoyang Zeng, Guiyuan Li, Wei Xiong, Bo Xiang, Mei Yi. Silencing AHNAK promotes nasopharyngeal carcinoma progression by upregulating the ANXA2 protein. Cellular Oncology 2024; 47(3): 833 doi: 10.1007/s13402-023-00898-3
|
| 21 |
Tianfeng Sun, Jing Zhang. ETV4 mediates the Wnt/β-catenin pathway through transcriptional activation of ANXA2 to promote hepatitis B virus-associated liver hepatocellular carcinoma progression. The Journal of Biochemistry 2021; 170(5): 663 doi: 10.1093/jb/mvab088
|
| 22 |
Michal Zygarowicz, Joanna Kacperczyk-Bartnik, Janusz Sierdzinski, Cezary Wojtyla, Piotr Pierzynski, Grzegorz Manka, Mariusz Kiecka, Robert Z Spaczynski, Piotr Piekarski, Beata Banaszewska, Artur Jakimiuk, Tadeusz Issat, Wojciech Rokita, Jakub Mlodawski, Maria Szubert, Piotr Sieroszewski, Grzegorz Raba, Kamil Szczupak, Tomasz Kluz, Marek Kluza, Michal Lipa, Damian Warzecha, Miroslaw Wielgos, Ewa Koc-Zorawska, Marcin Zorawski, Piotr Laudanski. Plasma and Peritoneal Fluid Annexin A2 Levels in Patients with Endometriosis. Journal of Inflammation Research 2023; : 5959 doi: 10.2147/JIR.S421389
|
| 23 |
Ema Elvira Herrera-López, Dafne Guerrero-Escalera, Isaac Aguirre-Maldonado, Arely López-Hernández, Hilda Montero, María Angélica Gutiérrez‐Nava, Luis del Pozo-Yauner, Jaime Arellanes-Robledo, Javier Camacho, Julio Isael Pérez-Carreón. Annexins A2 and A5 are potential early biomarkers of hepatocarcinogenesis. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-34117-8
|
| 24 |
Endrit Shahini, Giuseppe Pasculli, Antonio Giovanni Solimando, Claudio Tiribelli, Raffaele Cozzolongo, Gianluigi Giannelli. Updating the Clinical Application of Blood Biomarkers and Their Algorithms in the Diagnosis and Surveillance of Hepatocellular Carcinoma: A Critical Review. International Journal of Molecular Sciences 2023; 24(5): 4286 doi: 10.3390/ijms24054286
|
| 25 |
Jiajun Wang, Jinglai Lin, Jiahao Wang, Ying Wang, Yanjun Zhu, Xianglai Xu, Jianming Guo. Effect of Annexin A2 on prognosis and sensitivity to immune checkpoint plus tyrosine kinase inhibition in metastatic renal cell carcinoma. Discover Oncology 2024; 15(1) doi: 10.1007/s12672-024-00934-0
|
| 26 |
Na Liu, Min Liu, Mengwei Jiang, Zhenwei Li, Weijun Chen, Wenxuan Wang, Xianglei Fu, Man Qi, MD HASAN ALI, Nan Zou, Qingguang Liu, Hui Tang, Shenghui Chu. Isoliquiritigenin alleviates the development of alcoholic liver fibrosis by inhibiting ANXA2. Biomedicine & Pharmacotherapy 2023; 159: 114173 doi: 10.1016/j.biopha.2022.114173
|